← Back to Search

Behavioral Intervention

Policy and Training Intervention for Cannabis

N/A

Waitlist Available

Led By Gill Woodall, PhD

Research Sponsored by Klein Buendel, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 21 or older (by state law)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up establishments will be evaluated by pip assessments 4 times (including baseline) over 5 years

Awards & highlights

Study Summary

This trial aims to study the effectiveness of an intervention in reducing the risk of selling marijuana to obviously-intoxicated customers in the recreational marijuana market. The intervention will involve training store personnel to recognize signs of

Who is the study for?

This trial is for state-licensed recreational marijuana stores in Oregon. It aims to involve store personnel who will be trained to recognize and refuse sales to visibly intoxicated customers, potentially reducing impaired driving incidents.Check my eligibility

What is being tested?

The study tests a new intervention against usual policies. The intervention includes training staff on recognizing intoxication and refusing sales, paired with increased law enforcement deterrence of selling marijuana to intoxicated individuals.See study design

What are the potential side effects?

There are no direct physical side effects from the interventions being studied as they relate to policy and training procedures rather than medical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ establishments will be evaluated by pip assessments 4 times (including baseline) over 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~establishments will be evaluated by pip assessments 4 times (including baseline) over 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and establishments will be evaluated by pip assessments 4 times (including baseline) over 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Refusal Rate of Sales of Marijuana to Obviously-intoxicated Customers

Secondary outcome measures

Refusal Rate of Sales of Alcohol to Obviously-intoxicated Customers

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Policy and Training InterventionExperimental Treatment1 Intervention

This intervention includes the combination of a 2-hour policy meeting held by the Oregon Liquor and Cannabis Commission to teach the current laws around selling recreational marijuana as well as access to the TrainToTend program which contains 5 modules: The Laws, ID Checking, Health Effects, Customer Service, and Rules of the Trade

Group II: Usual and Customary Policy and Training (UC-PT) (Control) ConditionActive Control1 Intervention

This is basic Responsible Marijuana Vendor training currently provided by the Oregon Liquor and Cannabis Commission and includes reading a booklet on selling recreational marijuana responsibly and passing and exam

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Klein Buendel, Inc.Lead Sponsor

38 Previous Clinical Trials

19,294 Total Patients Enrolled

1 Trials studying Cannabis

448 Patients Enrolled for Cannabis

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

799 Previous Clinical Trials

1,362,282 Total Patients Enrolled

2 Trials studying Cannabis

810 Patients Enrolled for Cannabis

Pacific Institute for Research and EvaluationOTHER

26 Previous Clinical Trials

33,985 Total Patients Enrolled

1 Trials studying Cannabis

448 Patients Enrolled for Cannabis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently open for enrollment?

"According to the information available on clinicaltrials.gov, this trial is not currently seeking participants. The trial was originally posted on October 17th, 2023 and last updated on January 23rd, 2024. However, it is worth noting that there are presently 127 other trials actively searching for eligible individuals to participate in their respective studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers

2023. "Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06235632.